METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
South Korea
10-2018-7024215
Filed on 2017-02-14
10-2018-7024215
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Japan
2021-064539
Filed on 2021-04-06
2021-064539
Filed on 2021-04-06
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
European Patent
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
China
201780011505.X
Filed on 2017-02-14
201780011505.X
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Canada
3014674
Filed on 2017-02-14
3014674
Filed on 2017-02-14
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
Australia
2017221268
Filed on 2018-08-16
2017221268
Filed on 2018-08-16
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains
European Patent
20751027.2
Filed on 2020-07-17
20751027.2
Filed on 2020-07-17
FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME
US Patent 12,202,902
Filed on 2022-03-08
Filed on 2022-03-08
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
US Application 17/682,655
Filed on 2022-02-28
Filed on 2022-02-28
CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY
Hong Kong
62022051308.4
Filed on 2020-03-13
62022051308.4
Filed on 2020-03-13